← Back to Search

Physician Awareness for Pelvic Floor Dysfunction

N/A
Recruiting
Led By Thythy Pham, MD
Research Sponsored by Loyola University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day visit
Awards & highlights

Study Summary

This trial found that understanding a patient's preferences can help doctors meet expectations and improve patient satisfaction.

Who is the study for?
This trial is for Spanish-speaking adults who are visiting the Loyola Urogynecology clinic for the first time with pelvic floor disorders. They must be able to read, write, and speak in Spanish. It's not open to current patients of the clinic or those unable to complete study questionnaires.Check my eligibility
What is being tested?
The study is looking at how raising physician awareness about patient decision-making preferences affects care compared to usual treatment practices. The goal is to see if this improves satisfaction among patients who primarily speak Spanish.See study design
What are the potential side effects?
Since this trial focuses on physician-patient communication rather than medical treatments, there are no direct side effects from medications or interventions typically associated with clinical trials.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To compare Limited English Proficiency patients' preferred roles with actual roles in decision-making and determine how this is altered by the physicians' awareness of the patients' preferred roles.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Physician AwarenessExperimental Treatment1 Intervention
The physician will have access to the pre-visit Control Preference Scale survey results for women assigned to this group.
Group II: Usual CareActive Control1 Intervention
The physician will not have access to the pre-visit Control Preference Scale survey results for women assigned to this group.

Find a Location

Who is running the clinical trial?

Loyola UniversityLead Sponsor
156 Previous Clinical Trials
30,828 Total Patients Enrolled
Thythy Pham, MDPrincipal InvestigatorLoyola Medical Center
3 Previous Clinical Trials
265 Total Patients Enrolled

Media Library

Physician Awareness Clinical Trial Eligibility Overview. Trial Name: NCT05871268 — N/A
Limited English Proficiency Patients Research Study Groups: Physician Awareness, Usual Care
Limited English Proficiency Patients Clinical Trial 2023: Physician Awareness Highlights & Side Effects. Trial Name: NCT05871268 — N/A
Physician Awareness 2023 Treatment Timeline for Medical Study. Trial Name: NCT05871268 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to participate in this investigation?

"Eligibility for this medical experiment is restricted to individuals with limited English skills aged between 18 and 99. Altogether, 106 patients will be admitted into the trial."

Answered by AI

Does this experiment confer eligibility to persons aged 30 or more?

"This clinical trial allows participants aged between 18-99. Additionally, there is a separate cohort open to those under the age of 18 and another for individuals over 65 years old."

Answered by AI

Are there any open enrollment opportunities for this research study?

"Per the clinicaltrials.gov database, this medical trial is not currently inviting patients to join its study. The first posting was on June 1st 2023 and the most recent edits were made May 12th of the same year. Despite this, 24 other trials are actively recruiting volunteers for their experiments."

Answered by AI
~18 spots leftby Jun 2024